Literature DB >> 15490054

Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer.

Hussam M Binyousef1, Ali S Alzahrani, Saif S Al-Sobhi, Suhaibani Hamed S Al, Mohammed A Chaudhari, Hussain M Raef.   

Abstract

Surgical resection of persistent/recurrent (P/R) papillary thyroid cancer (PTC), when localized to the neck, is generally recommended; however, its impact on the course of the disease is not clear. We introduced a new technique in the form of preoperative neck ultrasonographic mapping (US-M) to improve the outcome of the surgical resection of P/R PTC. A total of 19 patients had undergone regional (central, lateral, or both) neck dissection before introducing the current technique (group 1, or G1), and 26 patients (group 2, or G2) had limited lymph node resection guided by US-M with findings accurately plotted on a standard diagram. All of the operations were performed by a single surgeon. The surgical outcomes of the two groups were compared. The resected lesions were positive for PTC in 17 patients (89.5%) in G1 and in 25 patients (96.2%) in G2. In G2, the intraoperative findings exactly matched the US-M in 23 patients (88.5%). Postoperatively, neck US became negative in 50% in G1 and in 83.3% in G2 (p = 0.02). Thyroglobulin (Tg) became undetectable in 37.5% in G1 and 52.3% in G2 (p = 0.37). Whole-body iodine scans (WBS) became negative in one of six patients (16.7%) in G1, and in three of four patients (75%) in G2, (p = 0.06). After a mean follow-up of 23.8+/-7.1 months in G1 and 9.8+/-4.7 months in G2, 6 patients (31.6%) in G1 and 15 patients (62.5%) in G2 were in remission (p = 0.04), whereas the disease persisted in 13 cases (68.4%) in G1 and 9 (37.5%) in G2 (p = 0.04). In conclusion, US-M improved the surgical outcome, as evidenced by the postoperative US, Tg, and WBS findings and the higher remission rate for the G2 patients than for the G1 patients.

Entities:  

Mesh:

Year:  2004        PMID: 15490054     DOI: 10.1007/s00268-004-7636-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Intraoperative ultrasonography improves identification of recurrent thyroid cancer.

Authors:  John K Karwowski; R Brooke Jeffrey; I Ross McDougall; Ronald J Weigel
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

2.  131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated?

Authors:  I R McDougall
Journal:  Thyroid       Date:  1997-08       Impact factor: 6.568

3.  Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer.

Authors:  L J DeGroot
Journal:  Am J Med       Date:  1994-12       Impact factor: 4.965

4.  US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer.

Authors:  R T Sutton; C C Reading; J W Charboneau; E M James; C S Grant; I D Hay
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

5.  Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients.

Authors:  F Pacini; L Agate; R Elisei; M Capezzone; C Ceccarelli; F Lippi; E Molinaro; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

6.  Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.

Authors:  Vahab Fatourechi; Ian D Hay; Houman Javedan; Gregory A Wiseman; Brian P Mullan; Colum A Gorman
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer.

Authors:  A S Alzahrani; H Raef; A Sultan; S Al Sobhi; S Ingemansson; M Ahmed; A Al Mahfouz
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

8.  Efficacy of sonographically guided biopsy of thyroid masses and cervical lymph nodes.

Authors:  G W Boland; M J Lee; P R Mueller; W Mayo-Smith; S L Dawson; J F Simeone
Journal:  AJR Am J Roentgenol       Date:  1993-11       Impact factor: 3.959

9.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

Review 10.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

Authors:  S K Grebe; I D Hay
Journal:  Surg Oncol Clin N Am       Date:  1996-01       Impact factor: 3.495

View more
  8 in total

1.  Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.

Authors:  Osama Al-Saif; William B Farrar; Mark Bloomston; Kyle Porter; Matthew D Ringel; Richard T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2010-03-23       Impact factor: 5.958

2.  Radioguided occult lesion localization for locally recurrent thyroid carcinoma.

Authors:  Mehmet Ali Gulcelik; Niyazi Karaman; Lutfi Dogan; Ilgın Sahiner; Gokhan Giray Akgul; Yavuz Selim Kahraman; Gulin Ucmak Vural
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-13       Impact factor: 2.503

3.  Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique.

Authors:  Oliver S Eng; Scott B Grant; Jason Weissler; Mitchell Simon; Sudipta Roychowdhury; Tomer Davidov; Stanley Z Trooskin
Journal:  Gland Surg       Date:  2016-12

4.  Role of charcoal tattooing in localization of recurred papillary thyroid carcinoma: initial experiences.

Authors:  Hyungju Kwon; Soon Young Tae; Su-Jin Kim; Kyeong Cheon Jung; Ji-Hoon Kim; Kyu Eun Lee; Yeo-Kyu Youn
Journal:  Ann Surg Treat Res       Date:  2015-02-27       Impact factor: 1.859

5.  Clinical and imaging assessment of cervical lymph node metastasis in papillary thyroid carcinomas.

Authors:  Yoon Jung Choi; Ji Sup Yun; Shin Ho Kook; Eun Choel Jung; Yong Lai Park
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

6.  Surgeon-performed ultrasound in patients referred for thyroid disease improves patient care by minimizing performance of unnecessary procedures and optimizing surgical treatment.

Authors:  Peter J Mazzaglia
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

7.  The relevance of preoperative ultrasound cervical mapping in patients with thyroid cancer.

Authors:  Davit Kocharyan; Frank Schwenter; Manon Bélair; Edgard Nassif
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

8.  The Value of Intraoperative Ultrasound in Selective Lateral Cervical Neck Lymphadenectomy for Papillary Thyroid Cancer: A Prospective Pilot Study.

Authors:  Giovanna Di Meo; Francesco Paolo Prete; Giuseppe Massimiliano De Luca; Alessandro Pasculli; Lucia Ilaria Sgaramella; Francesco Minerva; Francesco Antonio Logoluso; Giovanna Calculli; Angela Gurrado; Mario Testini
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.